Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).
Journal: Therapeutic advances in medical oncology
Published: May 28, 2018
"Everyone Deserves to be Remembered Like This": Videotaped Autobiography and End-of-Life Discussions Among Those With Serious or Terminal Illness.
Journal: Journal of pain and symptom management
Published: January 13, 2017
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 03, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026